1/69
Looks like no tags are added yet.
What is an antibiotic?
A chemical that kills or inhibits bacteria.
What is antibiotic resistance?
The ability of bacteria to survive or grow despite exposure to an antibiotic that would normally affect them.
No. Bacteria develop resistance; a person may experience an allergic reaction to a drug.
Invasion, proliferation, and colonization; nonspecific host response; specific immunity.
By producing and secreting chemicals or toxins that inhibit or kill other bacteria.
Honey.
Alexander Fleming, in 1928.
Bacterial growth was inhibited in the area surrounding the antibiotic.
8.2%.
21.5%.
The enzyme breaks down or modifies the beta-lactam antibiotic, preventing it from working.
The antibiotic cannot enter the bacterial cell in sufficient amounts to affect its target.
It pumps the antibiotic out of the cell, reducing its internal concentration.
The drug can no longer bind effectively to the altered target.
It has an alternative penicillin-binding protein, PBP2a, with low affinity for many beta-lactams.
Penicillins and cephalosporins.
Sulfonamides.
Fluoroquinolones.
Tetracyclines, aminoglycosides, and macrolides.
Efflux.
These patients may be especially vulnerable to infections and complications.
These organisms can resist important antibiotics, making infections harder to treat.
They expose bacteria to antibiotics and favor resistant bacteria over susceptible ones.
It exposes large bacterial populations to antibiotics, selecting for resistant bacteria.
Approximately 30% for humans and 70% for animals.
Rifampicin resistance.
Rifampicin kills susceptible bacteria, while resistant bacteria survive and reproduce.
Rifampicin.
Mutation, natural selection, gene flow, and genetic drift.
Resistance variants may already exist; antibiotics favor their survival and reproduction.
Susceptible bacteria are removed more effectively, increasing the resistant bacteria's relative frequency.
They can kill susceptible beneficial bacteria and select for resistant bacteria among the survivors.
It is one of the bacteria that can live as part of the normal gut flora.
On the skin.
Resistance genes can persist in these bacteria and potentially transfer to disease-causing bacteria.
Incorrect use can contribute to treatment failure and resistance; patients should follow their prescriber's directions.
The infection may persist or return, and treatment may become more difficult.
Antibiotics target bacterial structures or processes that viruses do not have in the same way.
Use antibiotics only when appropriately prescribed, follow medical instructions, and avoid unnecessary antibacterial products.
Through horizontal gene transfer.
Exposure may select for bacteria with resistance mechanisms that also protect them against certain antibiotics.
Using antibiotics for purposes other than treating a diagnosed illness, such as growth promotion or routine prevention.
Many animals and their bacteria are exposed in close quarters, creating opportunities for resistant bacteria to spread.
It reported that more than 50% were produced for agricultural use.
Through food, direct animal contact, or environmental routes such as contaminated water or waste.
Bacteria and resistance genes selected in animals can potentially reach humans.
Avoparcin use was associated with selection for resistance that could also affect vancomycin, an important human antibiotic.
Virginiamycin is related to Synercid, an antibiotic combination used in human medicine.
When one resistance mechanism makes a bacterium resistant to more than one related drug or compound.
An increase in resistant organisms and a limited supply of new antimicrobial drugs.
Antibiotics may offer lower financial returns than drugs used regularly for chronic conditions, while development is costly.
A situation in which resistant infections make antibiotics ineffective for conditions they once treated reliably.
An infection after surgery could be harder to treat if the bacteria resist available antibiotics.
It stated that such infections can cost at least twice as much as comparable non-resistant infections.
To encourage coordinated action and new efforts to address antimicrobial resistance.
A device that helps grow previously uncultured environmental microbes, supporting discovery of new antibiotics.
It was presented as a promising antibiotic discovered using the iChip approach.
It binds lipid building blocks involved in bacterial cell-wall synthesis.
New mechanisms of action may treat resistant bacteria that existing drugs cannot effectively control.
Discovery provides a drug that inhibits bacteria; resistance evolves when heritable variants survive exposure and reproduce.
Heritable variation in resistance and differential survival or reproduction under antibiotic exposure.
It reduces selective pressure favoring resistant bacteria.
It can reduce unnecessary selection for resistant bacteria in livestock and their environments.
Different resistance mechanisms: antibiotic inactivation, efflux, and target alteration.
It reduces unnecessary selection pressure that gives resistant bacteria a relative advantage.
No. Treatment may have selected for resistant bacteria that were already present or arose during the population's history.
They can act as a reservoir of resistance genes that may spread to pathogens.
Each can expose bacterial populations to compounds that select for resistant bacteria; some mechanisms may also produce cross-resistance.
Antibiotics impose selection pressure; heritable resistance allows some bacteria to survive, reproduce, and increase in frequency.